US Intravascular Catheter Market Research Report: By Application (Renal Disease, Cancer, Gastrointestinal Diseases, Infectious Diseases, other Diseases), By Product Type (Short PIVC Catheters, Integrated/Closed PIVC Catheters) and By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare, others) - Forecast to 2035.
US Intravascular Catheter Market Overview:
As per MRFR analysis, the US Intravascular Catheter Market Size was estimated at 2.29 (USD Billion) in 2023. The US Intravascular Catheter Market Industry is expected to grow from 2.7(USD Billion) in 2024 to 6.8 (USD Billion) by 2035. The US Intravascular Catheter Market CAGR (growth rate) is expected to be around 8.76% during the forecast period (2025 - 2035).
Key US Intravascular Catheter Market Trends Highlighted
The US Intravascular Catheter Market is experiencing significant growth driven by several key market drivers, including the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, which require frequent hospital visits and interventions. Furthermore, advancements in catheter design and technology are enhancing patient safety and comfort, leading to increased adoption in healthcare facilities across the nation. The increasing awareness of infection control and the development of antimicrobial catheters are also becoming pivotal in reducing healthcare-associated infections, thereby boosting market demand. Opportunities within the US market remain abundant, especially regarding the integration of smart catheter technology and telemedicine.As healthcare shifts towards more personalized patient care, the utilization of connected devices that can monitor patient condition remotely could transform how providers manage intravenous therapy. Moreover, growing support from government initiatives aimed at modernizing healthcare infrastructure offers manufacturers opportunities to collaborate with institutions to improve access to advanced medical devices. Recent trends indicate a heightened focus on regulatory compliance and clinical guidelines that emphasize patient safety and efficacy. The Food and Drug Administration (FDA) continues to enhance its oversight of medical devices, which has led to innovation and stricter safety standards within the market.Additionally, there is a noticeable shift towards value-based care models, incentivizing healthcare providers to focus on outcomes rather than procedures, which further influences the demand for innovative and effective intravascular solutions. Overall, the combination of these trends signals a dynamic and evolving landscape for the US Intravascular Catheter Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
US Intravascular Catheter Market Drivers
Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases such as cardiovascular disorders, diabetes, and cancer in the United States significantly drives the US Intravascular Catheter Market Industry. According to the Centers for Disease Control and Prevention (CDC), around 6 in 10 adults in the United States have at least one chronic disease, and these conditions often require invasive procedures for treatment. For instance, the American Cancer Society reports that there are over 1.8 million new cancer cases diagnosed each year in the U.S.alone. With the growing population of patients requiring intravenous therapies and monitoring, the demand for intravascular catheters is projected to rise. This trend highlights the necessity for healthcare providers to utilize advanced medical devices like intravascular catheters, persuading manufacturers to innovate and expand their offerings, ultimately stimulating market growth.
Technological Advancements in Catheter Design
Technological innovations in intravascular catheter design, such as the development of enhanced biocompatible materials and improved monitoring capabilities, contribute significantly to the growth of the US Intravascular Catheter Market Industry. Manufacturers such as Boston Scientific and Medtronic are continuously investing in Research and Development initiatives to create safer, more efficient catheters with features like antimicrobial coatings and real-time monitoring sensors.These advancements not only improve patient outcomes by reducing infection rates but also enhance the overall efficiency of medical procedures. A report from the Food and Drug Administration (FDA) indicates a marked increase in the approval of new catheter technologies, showcasing a potential growth trajectory for the market as healthcare facilities adopt these innovative solutions.
Expansion of Healthcare Infrastructure
The expansion of healthcare infrastructure in the United States, including the establishment of new hospitals and outpatient care centers, plays a vital role in the growth of the US Intravascular Catheter Market Industry. The American Hospital Association states that there are over 6,200 hospitals in the nation, alongside a growing number of outpatient centers, reflecting an increasing capacity to treat patients with various medical conditions. As these facilities become more prevalent, there is a higher demand for intravascular catheters to support various medical procedures.This growing infrastructure encourages healthcare providers to enhance their service offerings, leading to an increased usage of intravascular catheters, thereby propelling market growth.
Rising Geriatric Population
The increasing geriatric population in the United States is a significant driver of growth in the US Intravascular Catheter Market Industry. The U.S. Census Bureau estimates that the number of individuals aged 65 and older will reach nearly 95 million by the year 2060, representing approximately 23% of the total population. This demographic shift implies a higher prevalence of age-related health issues, including cardiovascular diseases and diabetes, which often necessitate the use of intravascular catheters for treatment and management.With established organizations like the National Institute on Aging actively working to address the healthcare needs of this population, the demand for specialized medical devices such as intravascular catheters is likely to escalate, highlighting the growth potential of this market.
US Intravascular Catheter Market Segment Insights:
Intravascular Catheter Market Application Insights
The US Intravascular Catheter Market, particularly within the Application segment, showcases a diverse array of medical applications critical to patient care. This segment addresses a variety of health challenges, with applications spanning renal disease, cancer, gastrointestinal diseases, and infectious diseases, among others. Each category plays a significant role in healthcare, particularly in the U.S., where the prevalence of chronic conditions demands advanced medical interventions. Renal disease is a major area of focus due to the increasing rate of kidney-related disorders, with intravascular catheters providing essential access for dialysis and other treatments. Meanwhile, cancer treatment modalities often rely on catheters for effective chemotherapy delivery and monitoring, underscoring the necessity of these devices in oncologic care. Gastrointestinal diseases also present various challenges, highlighting the importance of intravascular access for nutrition and medication administration in patients facing intestinal dysfunction. Infectious diseases have further heightened the reliance on intravascular catheters, especially with the rising incidence of hospital-acquired infections and the ongoing need for long-term antibiotic therapy in severe cases. Furthermore, the market addresses various other diseases, stressing the versatility of intravascular catheters across numerous medical applications. The current trends reflect a growth opportunity enhanced by technological advancements, such as the development of antimicrobial catheters aimed at reducing infection rates. These innovations signal robust market evolution driven by healthcare needs, emphasizing risk reduction and improved patient outcomes. The overall growth within the Application segment is propelled by various factors, including the aging U.S. population, increased healthcare expenditure, and a heightened focus on complex disease management strategies. This segment's importance is underscored by the U.S. government's commitment to improving health services, noting the integration of advanced medical devices as essential in modern healthcare delivery. Such insights into the US Intravascular Catheter Market segmentation reveal a landscape that is not only diverse but also crucial in meeting the demands of various health challenges across the nation. This segment demonstrates a dynamic interplay of innovation and necessity, driving forward the capabilities of medical professionals in their efforts to enhance patient care through enhanced accessibility and treatment efficacy.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Intravascular Catheter Market Product Type Insights
The US Intravascular Catheter Market is a critical segment of the healthcare industry, primarily focusing on various product types essential for delivering medications and fluids safely to patients. Among these, Short Peripheral Intravenous Catheters (PIVC) are vital due to their widespread usage in hospitals and outpatient settings, providing quick access for therapies and diagnostics while minimizing complications. Integrated or Closed PIVC Catheters have gained attention for their enhanced safety features, reducing the risk of infections associated with conventional catheters.The importance of these product types is underscored by the increasing prevalence of chronic diseases which necessitate long-term venous access. The market is also influenced by trends such as the growing emphasis on patient safety and the increasing adoption of aseptic techniques in medical procedures. Consequently, these innovations reflect the demand for more efficient and effective intravenous solutions, driving the evolution of the US Intravascular Catheter Market. Overall, the segmentation into these product types illustrates the industry's response to evolving clinical needs and regulatory standards aimed at improving patient outcomes.
Intravascular Catheter Market End User Insights
The US Intravascular Catheter Market is significantly influenced by its End User segment, which primarily consists of Hospitals, Clinics, Ambulatory Surgical Centers, Homecare, and other settings. Hospitals dominate this segment due to their extensive usage of intravascular catheters for critical care, surgical procedures, and patient management. Clinics and Ambulatory Surgical Centers are increasingly adopting these catheters, particularly for outpatient procedures, contributing to the surge in demand. Homecare settings represent an emerging area of growth as patients prefer receiving care at home, driving the need for innovative catheter solutions tailored for safety and ease of use.Additionally, advancements in catheter technology and increased emphasis on infection control practices are fostering positive developments across all end users. The rising population of geriatric patients and the prevalence of chronic diseases in the US further amplify the significance of this segment, reflecting a demand that aligns with broader healthcare trends. Overall, the dynamics at play within the End User segment offer vital insights into the ongoing developments in the US Intravascular Catheter Market, shaping its future trajectory and providing substantial opportunities for innovation and growth within the industry.
US Intravascular Catheter Market Key Players and Competitive Insights:
The US Intravascular Catheter Market is characterized by intense competition among various manufacturers and suppliers aiming to capture a significant share in this essential segment of the medical device industry. The market primarily serves hospitals, clinics, and surgical centers that require effective solutions for intravenous access, delivering medications, fluids, and nutrients safely and efficiently. With advancements in technology and a growing emphasis on patient safety, many companies are investing in innovative products that enhance clinical outcomes and reduce the risk of complications associated with catheter use. Additionally, the rising prevalence of chronic diseases and an aging population are driving demand for intravascular catheters, resulting in an increasingly competitive landscape where companies strive to differentiate their offerings through unique features and better user experiences.Teleflex has established a significant presence in the US Intravascular Catheter Market, driven by its robust portfolio of innovative medical devices designed for minimizing complications and enhancing patient care. The company's strength lies in its well-developed distribution network, which allows for widespread availability of its products, including single-lumen and multi-lumen catheters, among healthcare professionals. Teleflex focuses on developing catheters that reduce the risk of infections and improve ease of use, thus winning the trust of clinicians. The firm is recognized for its continuous commitment to research and development, enabling it to introduce cutting-edge solutions that resonate with both healthcare providers and patients. This commitment, coupled with strategic partnerships and collaborations, positions Teleflex as a robust contender in the competitive atmosphere of the US market.Smiths Medical holds a notable footprint within the US Intravascular Catheter Market, distinguished by its reliable and innovative product offerings, which primarily include intravenous catheters and associated devices. The company has a strong reputation for quality and efficacy in its catheter systems, focusing particularly on enhancing safety and efficiency for healthcare providers administering intravenous therapies. With a vast array of products tailored to various patient needs, including their advanced catheter and infusion systems, Smiths Medical maintains a competitive edge through ongoing investments in product innovation and technological advancements. Furthermore, the company has pursued strategic mergers and acquisitions to expand its market reach and enhance its product portfolio. This strategic approach allows Smiths Medical to respond swiftly to market changes, remain at the forefront of catheter technologies, and address the evolving demands of healthcare facilities across the country.
Key Companies in the US Intravascular Catheter Market Include:
Teleflex
Smiths Medical
Vygon
Baxter
CONMED
Medtronic
Boston Scientific
Keene Medical Products
Cardinal Health
Stryker
Cook Medical
Terumo
Halyard Health
Johnson and Johnson
BD
US Intravascular Catheter Market Industry Developments
Recent developments in the US Intravascular Catheter Market have included notable advancements and investments from key players such as Teleflex, Smiths Medical, and Medtronic, focusing on enhancing product functionality and patient safety. The market continues to experience growth, fueled by an increasing number of surgical procedures and the rising prevalence of chronic diseases, with market valuations expanding significantly, reflecting a steady demand for advanced catheter technologies. In the area of mergers and acquisitions, Baxter announced the acquisition of Hillrom in September 2021, which diversifies its portfolio in the healthcare sector and strengthens its presence in the catheter market. Additionally, BD has been actively expanding its capabilities through strategic partnerships aimed at innovation in catheter technology. Over the past few years, the market has witnessed increased regulatory focus on safety standards and quality control for medical devices, with the FDA emphasizing streamlined approvals to encourage innovation. This evolving regulatory landscape continues to impact product development and market dynamics. Overall, the US Intravascular Catheter Market remains a vibrant sector that is adapting to technological advancements and changing healthcare demands.
US Intravascular Catheter Market Segmentation Insights
Intravascular Catheter Market Application Outlook
Renal Disease
Cancer
Gastrointestinal Diseases
Infectious Diseases
other Diseases
Intravascular Catheter Market Product Type Outlook
Short PIVC Catheters
Integrated/Closed PIVC Catheters
Intravascular Catheter Market End User Outlook
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare
others
Report Scope:
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2018 |
2.29(USD Billion) |
MARKET SIZE 2024 |
2.7(USD Billion) |
MARKET SIZE 2035 |
6.8(USD Billion) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
8.76% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Billion |
KEY COMPANIES PROFILED |
Teleflex, Smiths Medical, Vygon, Baxter, CONMED, Medtronic, Boston Scientific, Keene Medical Products, Cardinal Health, Stryker, Cook Medical, Terumo, Halyard Health, Johnson and Johnson, BD |
SEGMENTS COVERED |
Application, Product Type, End User |
KEY MARKET OPPORTUNITIES |
Technological advancements in catheters, Increasing demand for outpatient procedures, Rising prevalence of chronic diseases, Growing focus on infection control, Expanding geriatric population with healthcare needs |
KEY MARKET DYNAMICS |
Technological advancements, Rising chronic diseases, Increasing geriatric population, Enhanced patient safety measures, Growing demand for minimally invasive procedures |
COUNTRIES COVERED |
US |
Frequently Asked Questions (FAQ) :
The US Intravascular Catheter Market is expected to be valued at 2.7 billion USD in 2024.
By 2035, the US Intravascular Catheter Market is projected to reach 6.8 billion USD.
The CAGR for the US Intravascular Catheter Market is anticipated to be 8.76% during the period from 2025 to 2035.
Key applications driving growth include renal disease, cancer, gastrointestinal diseases, and infectious diseases.
The market size for renal disease applications is expected to be 0.8 billion USD in 2024 and grow to 2.0 billion USD by 2035.
The cancer application segment of the US Intravascular Catheter Market is expected to reach 2.2 billion USD by 2035.
The gastrointestinal diseases application segment is projected to reach 1.5 billion USD by 2035 in the US Intravascular Catheter Market.
Major players in the market include Teleflex, Smiths Medical, Medtronic, and Boston Scientific.
For infectious diseases, the US Intravascular Catheter Market is expected to be valued at 0.4 billion USD in 2024 and grow to 1.0 billion USD by 2035.
Challenges could include regulatory hurdles, increasing competition among major players, and fluctuations in healthcare spending.